TARO(Delisted)
Taro Pharmaceutical Industries·NYSE
--
--(--)
Signals Analysis
Bullish signal 0
Bearish signal 1
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About TARO
Taro Pharmaceutical Industries Ltd.
A multinational pharmaceutical company that manufactures prescription and OTC generic drugs
14 Hakitor Street, Haifa Bay 2624761, Israel
--
Taro Pharmaceutical Industries Ltd., incorporated under the laws of Israel in 1959, is a science-based multinational pharmaceutical company. Tarot Pharma Industries develops, manufactures and markets prescription and OTC drugs primarily in the United States, Canada and Israel. The main focus areas of the Tarot pharmaceutical industry include pediatric creams and ointments, liquids, capsules and tablets, mainly in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories.
Company Financials
EPS
TARO has released its 2024 Q4 earnings. EPS was reported at 0.43, versus the expected 0.31, beating expectations. The chart below visualizes how TARO has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
TARO has released its 2024 Q4 earnings report, with revenue of 164.94M, reflecting a YoY change of 12.52%, and net profit of 15.08M, showing a YoY change of 118.11%. The Sankey diagram below clearly presents TARO's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
